Αποτελέσματα Αναζήτησης
11 Μαΐ 2022 · Lenacapavir is a first-in-class inhibitor of HIV-1 capsid function. 5 By interfering with capsid-mediated nuclear uptake of preintegration complexes and impairing virion production, lenacapavir...
6 Μαρ 2024 · A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are virologically suppressed, presented the Conference on Retrovirus and Opportunistic Infections (CROI) in Denver.
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
23 Δεκ 2021 · Apretude, a new drug approved by the FDA this week, is an injection that has proven to be significantly more effective at reducing the risk of sexually-acquired HIV.
16 Αυγ 2024 · Large randomised studies of new long-acting medications for the prevention and treatment of HIV have shown high effectiveness and acceptability.
27 Ιαν 2021 · This is the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month.
5 Αυγ 2022 · Cabotegravir is the latest WHO-recommended drug that protects against HIV infection. In January 2021, the agency approved the use of a vaginal ring coated with the anti-HIV drug dapivirine. And...
